Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?

Editorial

Tomohiro Iida. Br J Ophthalmol. 2007 Apr.

. 2007 Apr;91(4):407-8.

doi: 10.1136/bjo.2006.108753.

No abstract available

Conflict of interest statement

Competing interest: None.

Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.
Shimura M, Nakazawa T, Yasuda K, Shiono T, Nishida K. Shimura M, et al. Br J Ophthalmol. 2007 Apr;91(4):449-54. doi: 10.1136/bjo.2006.106336. Epub 2006 Oct 31. Br J Ophthalmol. 2007. PMID: 17077114 Free PMC article. Clinical Trial.

1. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 19851031796–1806. - PubMed
1. Early Treatment Diabetic Retinopathy Study Research Group Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology 198794761–774. - PubMed
1. Early Treatment Diabetic Retinopathy Study Research Group Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report No, 19. Arch Ophthalmol 19951131144–1155. - PubMed
1. Mcdonald H R, Schatz H. Grid photocoagulation for diffuse macular edema. Retina 1985565–72. - PubMed
1. Olk R J. Modified grid argon (blue‐green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 198693938–950. - PubMed